Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
The global market for fracture fixation products is expected to reach nearly $10.8bn by 2023, a CAGR of 5.9%. Internal fixation devices for small-bone fractures are expected to see the largest growth over the forecast period, according to a new analysis by Meddevicetracker.
Latest From Market Intelligence
The race continues to heat up in the bioprinting space over which players will first reach the finish line in gaining approval for tissue and organ replacements. Research organizations and companies worldwide are in various states of development for these milestones in regenerative medicine, ranging from bioprinting skin to a mini human heart. But regulatory hurdles and quality testing could be formidable.
The largest diagnostics companies, including Roche Diagnostics Corp., showcased their latest products at the recent American Association for Clinical Chemistry's (AACC) conference in Anaheim. See what David Smith, regional business manager for Roche's Navify decision-support portfolio, said about it here.
The recent AACC annual meeting drew more than 20,000 laboratory professionals to the Anaheim Convention Center. Medtech Insight caught up with the leading companies in the diagnostics space for a roundup of their latest product offerings and new developments.
In an interview with Medtech Insight, ZS' medtech marketing experts Matt Singer and Sundeep Karnik explain how companies can gain an competitive advantage by investing in their marketing operations, rather than restructuring their sales team, adding or subtracting new products, or overhauling their R&D programs.
Device Week, 2 August 2019 – Global Hearing Aid Market Growing Fast; Zimmer Biomet Continues Turnaround
In this week's podcast, Medtech Insight’s Catherine Longworth chats to Marion Webb about the growth of the global hearing aid market, which is set to rise from $7.7bn in 2018 to $11bn by 2023. Longworth also speaks to Reed Miller to discuss Zimmer Biomet’s second quarter results and its long-term plan to return to steady growth.
Market Intel: Large Providers Focus On Hemodialysis Home Care; New Incentive By Presidential Executive Order
Momentum is rising for patients with chronic kidney disease to be treated with hemodialysis in the comfort of their own home as opposed to traveling several days a week to a freestanding clinic. Manufacturers, government and payers are paving the way for a higher home-therapy adoption rate. That said, many patients remain unsuitable for home care and the large volume of water needed to operate hemodialysis can be logistically daunting.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.